Skip to main content
Top
Published in: Virchows Archiv 6/2010

01-12-2010 | Original Article

Warfarin embryopathy: fetal manifestations

Authors: Helen Wainwright, Peter Beighton

Published in: Virchows Archiv | Issue 6/2010

Login to get access

Abstract

During the period 1991–2007, autopsy was undertaken in 13 fetuses with warfarin embryopathy. Pregnancy data and radiographic babygrams were available in each instance. Gestational age ranged from 17 to 37 weeks. Eleven of the fetuses had the characteristic nasal hypoplasia, but only three had radiological epiphyseal stippling. Cerebral hemorrhage was a major feature of autopsy in 8 of the fetuses, and it is evident that bleeding is a significant factor in the pathogenesis of warfarin embryopathy. A wide variety of additional visceral manifestations which were observed at autopsy have been tabulated. There was no obvious correlation between maternal or gestational age and the presence and severity of any specific embryopathic feature. No information was available concerning the dose and timing of warfarin administration in this series.
Literature
1.
go back to reference Essop MR, Nkomo VT (2005) Rheumatic and nonrheumatic valvular heart disease: epidemiology, management and prevention in Africa. Circulation 112(23):3584–3591CrossRefPubMed Essop MR, Nkomo VT (2005) Rheumatic and nonrheumatic valvular heart disease: epidemiology, management and prevention in Africa. Circulation 112(23):3584–3591CrossRefPubMed
2.
go back to reference Choi C, Midwall S, Chaille P, Conti CR (2007) Treatment of mechanical valve thrombosis during pregnancy. Clin Cardiol 30(6):271–276CrossRefPubMed Choi C, Midwall S, Chaille P, Conti CR (2007) Treatment of mechanical valve thrombosis during pregnancy. Clin Cardiol 30(6):271–276CrossRefPubMed
3.
go back to reference Wainwright H, Beighton P (2010) Lethal epiphyseal stippling in the foetus and neonate; pathological implications. Virchows Arch 456:301–308CrossRefPubMed Wainwright H, Beighton P (2010) Lethal epiphyseal stippling in the foetus and neonate; pathological implications. Virchows Arch 456:301–308CrossRefPubMed
4.
go back to reference Hall JG, Pauli RM, Wilson KM (1980) Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 68(1):122–140CrossRefPubMed Hall JG, Pauli RM, Wilson KM (1980) Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 68(1):122–140CrossRefPubMed
5.
go back to reference Blickstein D, Blickstein I (2003) The risk of fetal loss with warfarin anticoagulation. Int J Gynaecol Obstet 78:221–225CrossRef Blickstein D, Blickstein I (2003) The risk of fetal loss with warfarin anticoagulation. Int J Gynaecol Obstet 78:221–225CrossRef
6.
go back to reference Howe AM, Hawkins JK, Webster WS (2004) The growth of the nasal septum in the 6–9 week period of foetal development — warfarin embryopathy offers a new insight into prenatal facial development. Aust Dent J 49(4):171–176CrossRefPubMed Howe AM, Hawkins JK, Webster WS (2004) The growth of the nasal septum in the 6–9 week period of foetal development — warfarin embryopathy offers a new insight into prenatal facial development. Aust Dent J 49(4):171–176CrossRefPubMed
7.
go back to reference Raghav S, Reutens D (2007) Neurological sequelae of intrauterine warfarin exposure. J Clin Neurosci 1114(2):99–103CrossRef Raghav S, Reutens D (2007) Neurological sequelae of intrauterine warfarin exposure. J Clin Neurosci 1114(2):99–103CrossRef
8.
go back to reference Masamoto H, Uehara H, Mekaru K, Uezato T, Sakumoto K, Aoki Y (2009) Warfarin-associated fetal intracranial hemorrhage in woman with mitral valve replacements: a case report. Am J Perinatol 26(8):597–600CrossRefPubMed Masamoto H, Uehara H, Mekaru K, Uezato T, Sakumoto K, Aoki Y (2009) Warfarin-associated fetal intracranial hemorrhage in woman with mitral valve replacements: a case report. Am J Perinatol 26(8):597–600CrossRefPubMed
9.
go back to reference Rehle T, Shisana O (2009) National population-based HIV surveys — the method of choice for measuring the HIV epidemic. S Afr Med J 99:633–636PubMed Rehle T, Shisana O (2009) National population-based HIV surveys — the method of choice for measuring the HIV epidemic. S Afr Med J 99:633–636PubMed
10.
go back to reference Mehndiratta S, Suneja A, Gupta B, Bhatt S (2010) Fetotoxicity of warfarin anticoagulation. Arch Gynecol Obstet 282:335–337CrossRefPubMed Mehndiratta S, Suneja A, Gupta B, Bhatt S (2010) Fetotoxicity of warfarin anticoagulation. Arch Gynecol Obstet 282:335–337CrossRefPubMed
11.
go back to reference Chan WS, Anand S, Ginsberg JS (2000) Anticoagnulation of pregnant women with mechanical heart valves. Arch Int Med 160:191–196CrossRef Chan WS, Anand S, Ginsberg JS (2000) Anticoagnulation of pregnant women with mechanical heart valves. Arch Int Med 160:191–196CrossRef
12.
go back to reference Van Kuilenburg JT, Verheugt FW, van Dijk AP (2007) Prosthetic heart valve thrombosis, anticoagulation and pregnancy: a case report and review of the literature. Neth Heart J 15(9):306–309CrossRefPubMed Van Kuilenburg JT, Verheugt FW, van Dijk AP (2007) Prosthetic heart valve thrombosis, anticoagulation and pregnancy: a case report and review of the literature. Neth Heart J 15(9):306–309CrossRefPubMed
13.
go back to reference Ginsberg JS, Chan WS, Bates SM, Kaatz S (2003) Anticoagulation of pregnant women with mechanical heart valves. Arch Int Med 163:694–698CrossRef Ginsberg JS, Chan WS, Bates SM, Kaatz S (2003) Anticoagulation of pregnant women with mechanical heart valves. Arch Int Med 163:694–698CrossRef
14.
go back to reference Pieper PG, Balci A, Van Dijk AP (2008) Pregnancy in women with prosthetic heart valves. Neth Heart J 16:406–411CrossRefPubMed Pieper PG, Balci A, Van Dijk AP (2008) Pregnancy in women with prosthetic heart valves. Neth Heart J 16:406–411CrossRefPubMed
15.
go back to reference Srivastava AR, Modi P, Sahi S, Niwariya Y, Singh H, Banerjee A (2007) Anticoagulation for pregnant patients with mechanical heart valves. Ann Card Anaesth 10(2):95–107CrossRefPubMed Srivastava AR, Modi P, Sahi S, Niwariya Y, Singh H, Banerjee A (2007) Anticoagulation for pregnant patients with mechanical heart valves. Ann Card Anaesth 10(2):95–107CrossRefPubMed
16.
go back to reference Khan AO (2007) Optic nerve dysfunction in a child following low-dose maternal warfarin exposure. Ophthalmic Genet 28(3):183–184CrossRefPubMed Khan AO (2007) Optic nerve dysfunction in a child following low-dose maternal warfarin exposure. Ophthalmic Genet 28(3):183–184CrossRefPubMed
Metadata
Title
Warfarin embryopathy: fetal manifestations
Authors
Helen Wainwright
Peter Beighton
Publication date
01-12-2010
Publisher
Springer-Verlag
Published in
Virchows Archiv / Issue 6/2010
Print ISSN: 0945-6317
Electronic ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-010-0982-9

Other articles of this Issue 6/2010

Virchows Archiv 6/2010 Go to the issue

Review and Perspective

Book review